Lanreotide | Drugs | BNF | NICE
View lanreotide information, including dose, uses, side-effects, pregnancy, breast feeding, monitoring requirements and directions for administration.
Lanreotide (Somatuline) - Cancer Research UK
Lanreotide is a synthetic version of somatostatin (a somatostatin analogue). It helps to control the symptoms of carcinoid syndrome and slow down the growth of the cancer. Some of the …
BNF therapeutic class / mode of action: Pituitary and hypothalamic hormones and analogues / somatostain analogues which have a range of actions on various endocrine, neuroendocrine, …
Octreotide and lanreotide are pharmacological options for treatment of acromegaly, symptoms of which result primarily from the effects of excess growth hormone and insulin- like growth factor …
Medicinal forms | Lanreotide | Drugs | BNF | NICE
BNF; Drugs; Lanreotide; Medicinal forms; Lanreotide Medicinal forms. View lanreotide drug monograph. Navigate to section. ... Lanreotide 60mg/0.5ml solution for injection pre-filled …
Lanreotide: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年4月23日 · Lanreotide (Somatuline Depot) is an injectable medication containing a man-made (synthetic octapeptide) version of a hormone produced by your body called …
Octreotide and lanreotide are recommended for the treatment of secretory gastrointestinal disorders (e.g. enterocutaneous fistula, high output stoma and refractory diarrhoea). Initiation …
Lanreotide - Lancashire and South Cumbria Medicines …
Lanreotide are recommended for the non-acute treatment of recurrent gastrointestinal bleeding disorders. Initiation and continued supply of lanreotide is the responsibility of hospital or …
lanreotide (Somatuline® Autogel®) - All Wales Therapeutics and ...
2018年9月20日 · Lanreotide (Somatuline® Autogel®) is recommended as an option for use within NHS Wales for the treatment of grade 1 and a subset of grade 2 (Ki67 index up to 10%) …
Lanreotide: BNF Code 0803043P0 - OpenPrescribing
High-level prescribing trends for Lanreotide (BNF code 0803043P0) across all GP practices in NHS England for the last five years. You can see which Sub-ICB Locations prescribe most of …